首页>
外国专利>
Use of an ERbeta Selective ligand or a Pharmaceutical composition thereof for the treatment of acute lung injury.
Use of an ERbeta Selective ligand or a Pharmaceutical composition thereof for the treatment of acute lung injury.
展开▼
机译:ERbeta选择性配体或其药物组合物在治疗急性肺损伤中的用途。
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a method of treating acute lung injuries, such as acute lung injury induced by peritonitis during sepsis, acute lung injury induced by intravenous bacteremia during sepsis, acute lung injury caused by smoke inhalation, acute lung injury occurring in a premature infant with deficiency of surfactant, acute lung injury caused by oxygen toxicity or acute lung injury caused by barotraumas from mechanical ventilation, using an ERbeta selective ligand such as 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol or 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile. The present invention further relates to use of ERbeta selective ligands or compositions thereof for the prevention of acute lung injuries in those being at risk thereof.
展开▼